|
Un nouveau traitement expérimental a été prodigué à
l'hôpital Bryn Mawr, en Pensylvanie. Une thérapie d'oxygène aqueux (traduction libre...)
consiste à injecter une solution de liquide salin, d'oxygène concentré et
de sang du patient directement dans l'artère coronaire atteinte, dans le but de
la réoxygéner rapidement. Le tout dure 90 minutes.
Le Dr Jack Martin espère augmenter la santé et
l'espérance de vie à long terme du patient.
Serait-ce le retour de "Aquaman" ???
André Beaulieu
T.A paramédic
Mtl-Laval
Texte original:
Oxygen Therapy for Heart
Attacks
Main Line Health cardiologist Jack Martin, M.D., was recently the
first physician in the nation to perform this new protocol. The procedure was
performed at Bryn Mawr Hospital, one of four initial U.S. sites approved by the
FDA to handle the first 20 cases in a phase two clinical study. Dr. Martin, who
serves as chief of Interventional Cardiology for Main Line Health, first
performed the new therapy on a man in his 50s who is recovering well at his
Newtown Square home. Dr. Martin has since treated five patients.
“As an adjunct to current interventional procedures, this technology may
boost the benefit to the heart muscle, improving its pumping function,” said Dr.
Martin. “AO therapy could dramatically change our approach to the treatment of
heart attack patients, and could have a significant impact on their survival and
long-term health.” During a major heart attack, blockages in the blood vessels
cut off the flow of blood and oxygen to the heart muscle. The sooner oxygen flow
is restored, the greater the chance of limiting the size of the heart attack and
salvaging more heart muscle from irreversible damage. Balloon angioplasty and
stents, standard treatment at specialized centers such as Bryn Mawr Hospital,
provide substantial benefits, but the AO therapeutic treatment strives to go one
step further.
In the 90-minute procedure, a solution of highly concentrated oxygen and
saline is mixed with the patient’s blood. The resulting super-oxygenated blood
is then delivered via a special catheter back to the patient’s coronary artery,
reoxygenating the affected area. This new therapeutic protocol utilizes improved
equipment that facilitates the application of this treatment in the emergency
setting. LIEN INTERNET: http://www.mainlinehealth.org/heart/e3front.dll?durki=14237 |
